Cargando…
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
Pediatric chronic kidney disease (CKD) is characterized by many co-morbidities, including impaired growth and development, CKD-mineral and bone disorder, anemia, dysregulated iron metabolism, and cardiovascular disease. In pediatric CKD cohorts, higher circulating concentrations of fibroblast growth...
Autores principales: | Hanudel, Mark R., Laster, Marciana L., Portale, Anthony A., Dokras, Aditi, Quigley, Raymond P., Guzman, German A. Lozano, Zaritsky, Joshua J., Hayde, Nicole A., Kaskel, Frederick J., Mitsnefes, Mark M., Ramirez, Jorge A., Imani, Peace D., Srivaths, Poyyapakkam R., Kogon, Amy J., Denburg, Michelle R., Blydt-Hansen, Tom D., Reyes, Loretta Z., Greenbaum, Larry A., Weidemann, Darcy K., Warady, Bradley A., Elashoff, David A., Mendley, Susan R., Isakova, Tamara, Salusky, Isidro B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437144/ https://www.ncbi.nlm.nih.gov/pubmed/35237863 http://dx.doi.org/10.1007/s00467-022-05492-7 |
Ejemplares similares
-
Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis
por: Pratt, Raymond D., et al.
Publicado: (2018) -
Mechanism of Action and Clinical Attributes of Auryxia(®) (Ferric Citrate)
por: Ganz, Tomas, et al.
Publicado: (2019) -
Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease
por: Hanudel, Mark R., et al.
Publicado: (2022) -
Antiviral effects of ferric ammonium citrate
por: Wang, Hongbin, et al.
Publicado: (2018) -
Physicochemical characterization of ferric pyrophosphate citrate
por: Gupta, Ajay, et al.
Publicado: (2018)